Questions and Answers on Biosimilar Development and the BPCI Act Guidance for Industry: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 17, 2021
September 17, 2021
37eb8581-8678-45a9-bb8d-7e8754cae01a
Related Documents
The “Deemed to be a License” Provision of the BPCI Act: Questions and Answers : Guidance for Industry
Guidance DocumentMarch 4, 2020Center for Drug Evaluation and Research
Field Alert Report Submission: Questions and Answers Guidance for Industry: Guidance for Industry
Guidance DocumentJuly 22, 2021Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox